Article
Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.
Post reproductive health - 1 Mar 2023
Manley Kristyn, Ryan Neil, Jenner Abigail, Newton Claire, Hillard Timothy
Abstract excerpt
path_BRCA 1/2 increases a woman's lifetime risk of breast and ovarian cancer. Interventions can be offered which manage cancer risk; annual breast screening from age 30, chemoprevention and, once a woman's family is complete, risk-reducing surgery. The latter is the most effective method of reducing cancer in path_BRCA carriers; salpingo-oophorectomy reduces breast and ovarian cancer, respectively, by up to 50%...
Topics
- Female
- Humans
- Adult
- Ovariectomy
- Salpingo-oophorectomy
- Heterozygote
- Hormone Replacement Therapy
- Ovarian Neoplasms
- Mutation
- Breast Neoplasms